FIELD: medicine; pharmacology.
SUBSTANCE: invention concerns application of alpha-aminoamides of formula for production of medical product for headache treatment including cerebrum vasorelaxation mechanism and treatment method of specified states.
EFFECT: high efficiency and absence of by-effects.
13 cl, 1 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
α -AMINOAMIDE DERIVATIVES APPLICABLE AS ANTI-INFLAMMATORY AGENTS | 2004 |
|
RU2396251C2 |
ALPHA-AMINOAMIDE DERIVATIVES USED FOR TREATING LOWER URINARY TRACT DISORDERS | 2005 |
|
RU2395504C2 |
METHOD OF USAGE OF (HALO BENZYLOXY)BENZYLAMINO-PROPANAMIDE FOR PRODUCTION OF MEDICATIONS WITH SELECTIVE MODULATING ACTIVITY ON SODIUM AND/OR CALCIUM CHANNELS | 2005 |
|
RU2391973C2 |
PHARMACEUTICAL COMPOSITION CONTAINING GABAPENTIN OR ITS ANALOG AND α-AMINOAMIDE AND ITS USING AS ANALGESIC | 2002 |
|
RU2295337C2 |
α-AMINOAMIDE DERIVATIVES EFFECTIVE IN TREATING RESTLESS LEGS SYNDROME AND ADDICTIVE DISORDERS | 2005 |
|
RU2403030C2 |
3-AMINOPYRROLIDONE DERIVATIVES | 2004 |
|
RU2395495C2 |
N-ACYL-N' -BENZYLALYLENEDIAMNO DERIVATIVES | 2004 |
|
RU2387636C2 |
2-PHENYLETHYLAMINO DERIVATIVES AS CALCIUM AND/OR SODIUM CHANNEL MODULATORS | 2006 |
|
RU2397160C9 |
METHOD OF MULTIMODAL ANALGESIA IN NEUROLOGICAL DEFICIENCY OF 1 DEGREE, ACCOMPANIED BY PAIN WITHOUT PROPRIOCEPTIVE DISORDERS IN DOGS WITH INTERVERTEBRAL DISC DISEASES HANSEN 1, HANSEN 2 AND LUMBOSACRAL STENOSIS | 2024 |
|
RU2824404C1 |
CYCLOPENTYL DERIVATIVES | 2004 |
|
RU2372325C2 |
Authors
Dates
2008-10-20—Published
2003-11-18—Filed